Healthy Japanese
Conditions
Interventions
Duration: Four weeks Test product: Hydrogen-oxygen generator HYDINA Administration: Inhale hydrogen-oxygen for 30 minutes daily using the hydrogen-oxygen generator HYDINA set at 3000 mL/min.
Sponsors
national university corporation Tokushima University
Bow Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Japanese 2. Women 3. Individuals aged between 20 and 60 4. Healthy individuals 5. Individuals who have never used any hydrogen-oxygen generator
Exclusion criteria
Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, stroke disorder, dyslipidemia, hypertension, neoplastic disease, hemorrhagic disease, infectious disease, amyotrophy, heart disease, disc herniation, ossification of the posterior longitudinal ligament, spondylosis deformans, spinal stenosis, osteoporosis, atlantoaxial subluxation, unstable spine, scoliosis, spina bifida, spondylolisthesis, or any other chronic diseases 4. Individuals who take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional foods/beverages on a daily basis 5. Individuals who are currently taking medications (including herbal medicines) and supplements 6. Individuals who are allergic to medicines and foods related to the test food 7. Individuals who are pregnant, lactating, or planning to become pregnant during this study 8. Individuals who suffer from COVID-19 9. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 10. Individuals who are judged as ineligible to participate in this study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Blood test and vascular age | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Questionnaires and medical record | — |
Countries
Japan
Contacts
Public ContactHirokazu Nakao
Eauzaura Co., Ltd. Product Planning Department
Outcome results
None listed